Research Projects
“Preclinical Study for a Phase I/Ib Clinical Trial Using CAR-T Cells Targeting the Tumor Stromal Antigen EDA in Patients with EDA-Positive Solid Tumors (EDAMATRIX)
Researcher | Principal Investigator
Immunomodulation and Tumor Microenvironment Research Group
Research Division
Cancer Division
Research program
Immunology and Immunotherapy
Research group
Immunomodulation and Tumor Microenvironment
Project information
Research project titled “Preclinical Study for a Phase I/Ib Clinical Trial Using CAR-T Cells Targeting the Tumor Stromal Antigen EDA in Patients with EDA-Positive Solid Tumors (EDAMATRIX),” conducted by the Immunomodulation and Tumor Microenvironment Research Group at CIMA, University of Navarra.
Project PDC2025-166182-I00 funded by MICIU/AEI/10.13039/501100011033
- Convocation: FIMA 2025 MCIU - AEI PROYECTOS DE I+D+I PARA LA REALIZACIÓN DE PRUEBAS DE CONCEPTO
- Reference: PDC2025-166182-I00
- Start date: February 1, 2026
- End date: January 31, 2028
- Funder: Ministerio de Ciencia, Innovación y Universidades
- Nature of project: National
- Award year 2026
Need more information?
If you are interested in learning more about our research, please contact us.